About
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
Team & affiliation
Founders: Ulrich Gartner, Jayson Dallas.
Timeline
- 2019Founded
- 2020Pre-seed / friends & family
- 2021Seed round
- 2022Series A
- 2023Series B
Region context
The Central Virginia cluster includes 55 other tracked listings. Central Virginia centers on UVA-adjacent biotech, climate, and software companies, with Lynchburg manufacturing nearby.
See all listings in CVL →